SUMMARY A patient with Niemann-Pick disease is reported together with family studies. Her liver and bone marrow were shown to be infiltrated with sea blue histiocytes. Other organs, spleen and lung, were presumably also involved but histological proof was not obtained. Enzyme assay of leucocytes, lymphocytes, and cultured skin fibroblasts showed the patient to be deficient in sphingomyelinase activity. In fibroblasts, activity was 5 % of normal while for the parents activity was about 50 % of normal. The expected partial deficiency was not found using leucocytes or lymphocytes from the parents. Heat stability studies on fresh fibroblast extracts from the propositus indicated that residual sphingomyelinase activity was slightly more labile than that of the controls. It seems clear that chronic Niemann-Pick disease without neurological involvement is associated with sea blue histiocytosis.
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In 1947, the term 'blue histiocyte' was used by Moeschlin (1947) to describe macrophages found in the spleen of an adult with unexplained splenomegaly. The cytoplasm of these cells was packed with numerous granules of varying sizes which stained blue with Romanowsky dyes. Silverstein et al. (1970) coined the term 'syndrome of the sea blue histiocyte' to describe a relatively benign condition characterized by hepatosplenomegaly and mild thrombocytopenia. This syndrome has been extensively reviewed by Sawitsky et al. (1972) and Silverstein and Ellefson (1972) .
Sea blue histiocytes have also been recorded in a wide variety of other conditions, including such diseases as chronic myeloid leukaemia (Steinberg and Dreiling, 1973) and abnormalities of lipid metabolism such as lecithin-cholesterol acyl transferase deficiency (Hovig and Gjone, 1973) . In 1964, Lynn and Terry described a patient with adult Niemann-Pick disease and found foamy cells in the marrow which resembled sea blue histiocytes. Golde et al. (1975) reported partial deficiency of sphingomyelinase in the fibroblasts of three siblings with sea blue histiocytosis. Further cases of this association have been described (Long et al., 1977; Wenger et al., 1977; Fried et al., 1978) . In this report we describe a Received for publication 23 April 1979 further patient suffering from non-neuropathic Niemann-Pick disease. Full clinical, biochemical, and ultrastructural details are described. The family differs in certain significant respects from previously published cases.
Case report
The patient, the youngest of four children, was born to Scottish parents who were not related, and there was no significant family medical history. She was delivered at term and examination at birth was normal. No perinatal complications were recorded, and she achieved her motor milestones at the appropriate age.
She presented to hospital aged 7 years with listlessness, abdominal pain, and distension. Examination revealed a thin girl below the third percentile for both weight and height. Other significant clinical findings were enlargement of the liver to 12 cm and the spleen to 8 cm below the costal margin, palmar erythema, and spider naevi. Neurological examination was normal and there was no evidence of intellectual impairment. Haemoglobin, white blood count, platelets, and liver function tests were also normal. A chest x-ray showed a reticulostriate pattern suggestive of a diffuse infiltration. Liver biopsy was performed at laparotomy and (Dacie and Lewis, 1975) showed a shortened half-life of 17 days and a splenic red cell pool of 0-145 1 (upper limit of normal 0.036).
In addition, the plasma volume was expanded at 0.59 I/kg (0.04-0.05). The white cell count was 1.5 x 109/l (neutrophils 0O8 x 109/1) and the platelet count 95 x 109/1. The concentration of clotting factors in the blood was also abnormal; factors II, V, VII, IX, and X (Dacie and Lewis, 1975) were reduced (Table 1 ) and the prothrombin ratio, 1-6, failed to correct after an adequate dosage of vitamin K. Chromosomal studies revealed a normal female karyotype. Bone marrow aspiration yielded hypercellular normoblastic marrow. This was infiltrated with abnormal cells, some of which closely resembled sea blue histiocytes in both colour and size (Fig. 1) ; others had foamy cytoplasm (Fig. 2) . The inclusions were only weakly PAS positive. Electron microscopy was also performed (Fig. 3) . The cells were large and contained numerous vacuoles lined with single membranes which contained loosely packed lamellar structures.
Liver function tests were abnormal (bilirubin 29 A chest x-ray showed generalised infiltration as before, and pulmonary function tests showed a mild restrictive defect (FEV1 1 95 1, FVC 2.2 1; predicted 2-5, 2.8) with a diminished transfer factor for carbon monoxide 4.34 mmol ml-1 kPa-1 (predicted 8.53).
BIOCHEMICAL STUDIES
Leucocytes were separated from fresh heparinised blood after dextran sedimentation (Snyder and Brady, 1969) and lymphocytes were isolated by Ficoll-Hypaque sedimentation (Boyum, 1968) . The cells were washed in isotonic sodium chloride and stored for up to two months as pellets at -70C. For thermal stability studies fibroblast extracts were treated as described (Schneider et al., 1978) .
Fresh extracts were preincubated at 50°C in the presence of 25 mM-citrate-phosphate buffer, pH 6-0, containing 10 mg/ml sodium taurocholate (crude extract, Sigma Chemical Co Ltd) and 2 mg/ml Cutscum (kindly donated by Dr A. D. Patrick, London).
For enzyme assay, pellets were extracted with sodium cholate (Besley, 1977) , and sphingomyelinase activity was determined using both the natural substrate (N-methyl-14C)-sphingomyelin (Radiochemical Centre, Amersham, Bucks) and its chromogenic analogue, 2-hexadecanoylamino 4-nitrophenylphosphorylcholine (HNP, Koch-Light Labs Ltd). Assay with the natural substrate was as described previously (Besley, 1977) . The incubation mixture (0-2 ml) contained cell extract (50-200 jug protein), 250 gg sodium cholate, 68 nmoles (A4C)-sphingomyelin (40 000 cpm), 20 ,umoles sodium acetate buffer, pH 5 0, and 0.025 % (v/v) Triton X-100. Incubation was for 2 hours (fibroblast extracts) or 3 hours (white cell extracts). Assay of sphingomyelinase activity with HNP was as described by Gal et al. (1975) , but, in the presence of 0.05% (v/v) Triton X-100 and /-hexosaminidase activity, was determined (Besley, 1977 ) using 4-methylumbelliferyl-2-acetamido-2-deoxy-3-D-glucopyranoside (Koch-Light Labs Ltd) as substrate. Protein was measured (Lowry et al., 1951) using bovine serum albumin as standard. Tables 2 and 3 summarise sphingomyelinase activities of white blood cells. In lymphocytes, activities were two to three times higher than those of dextran-separated leucocytes, the preparation generally used for the investigation of lysosomal storage disorders. For each cell preparation, sphingomyelinase activity was markedly deficient in cells from the affected case, but in lymphocytes the deficiency (6% of controls) was more pronounced. Neither cell preparation exhibited the partial enzyme deficiency expected for both parents (obligate heterozygotes). Although erythrocyte contamination was evident in the maternal lymphocyte preparation, the activity of a reference enzyme, /3-hexosaminidase, indicated that neither contamination nor incomplete enzyme extraction was responsible for the low sphingomyelinase activity in these heterozygous lymphocytes.
Sphingomyelinase activity in cultured fibroblasts was considerably higher ( (Silverstein and Ellefson, 1972) . It is likely that in some cases the sea blue histiocyte is a macrophage which has ingested large amounts of particulate lipid in the process of clearing such particles from the blood and tissues and cannot digest them (Parker et al., 1976) . Lynn and Terry (1964) described a 19-year-old patient with foamy cell infiltration of bone marrow and lymph nodes. Sphingomyelinase was not measured nor was it measured in the three cases of Long et al. (1977) , who resembled our patient clinically.
Of nine cases reported by Wenger et al. (1977) , all had neurological involvement and thus are different from our family. In addition, the levels of sphingomyelinase reported did not approach the low level (5 %) seen in our patient, the lowest level in their patient being 12%. In the case of Golde et al. (1975) , in which sea blue histiocytes were well described, sphingomyelinase activity averaged 18% of control levels, but more recent evidence (Schneider et al., 1978) has shown that this residual sphingomyelinase activity is thermolabile. This new form of Niemann-Pick disease was designated type F. Two affected families were described in which the clinical expression of the disease closely resembled that of our patient. There was a considerable difference in terms of the amount of residual activity and the degree of thermal stability of sphingomyelinase in the two families described with Niemann-Pick disease type F (Schneider et al., 1978) . Because of these differences it is not possible definitely to categorise our patient within this new group. Under the same assay conditions, sphingomyelinase activity in fibroblasts from our patient was similar to that (about 3 % of controls) measured in two patients with Niemann-Pick disease type B but somewhat higher than that (less than 1 % of controls) in four cases of Niemann-Pick disease type A.
Our results, in addition, show that the assay of sphingomyelinase activity in white blood cells may be of limited value in the recognition of heterozygotes, and consequently the state of the two sisters studied here could not be determined. The unreliability of such assay extends to lymphocyte preparations as well as to dextran-separated leucocytes in terms of heterozygote detection. Finally, the findings with regard to sphingomyelinase are consistent with an autosomal recessive inheritance of Niemann-Pick disease.
The coagulation abnormalities reported are similar to those found in the case of Long et al., though in our patient the bleeding time was normal despite the low platelet count. All the factors produced by the liver (II, V, VII, IX, X), apart from fibrinogen, were reduced; factor VIII was increased. This pattern is consistent with liver disease but it is not inconceivable that hypersplenism with resultant expansion in plasma volume (diluting the clotting factors) and increased intrasplenic utilisation of factors may contribute to such a picture. Certainly we have seen similar abnormal values in a young patient with massive splenomegaly, due to an unknown underlying cause, revert to normal after splenectomy (personal observations).
We have not performed splenectomy. In only one patient, closely resembling ours clinically, was splenectomy undertaken (Long et al., 1977) . The result appeared satisfactory but the follow-up period was not specified. We are concerned that removal of the spleen in our patient might lead to more marked infiltration of vital organs, for example the lung and liver. 
